Consolidated Statements of Operations (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Revenues	$ 4,055,575	$ 2,523,912
Cost of revenues	3,825,444	2,392,089
Research and development	4,759,083	3,161,326
Selling, general, and administrative	8,970,016	5,801,872
Total operating costs and expenses	17,554,543	11,355,287
Operating loss	(13,498,968)	(8,831,375)
Other income (expense):
Other income (expense), net	(189,551)	10,606
Interest expense	(94,156)	(43,560)
Nonoperating Income (Expense), Total	(283,707)	(32,954)
Loss before provision for income taxes and noncontrolling interests	(13,782,675)	(8,864,329)
Provision for income taxes	47,409	0
Net loss	(13,830,084)	(8,864,329)
Less - loss attributable to noncontrolling interests	(148,027)	(63,754)
Net Income (Loss) Available to Common Stockholders, Basic	(13,682,057)	(8,800,575)
Amounts Attributable to NeoStem, Inc. common stockholders:
Net Income (Loss) Available to Common Stockholders, Basic	$ (13,682,057)	$ (8,800,575)
NeoStem, Inc. common stockholders	$ (0.49)	$ (0.53)
Weighted average common shares outstanding	28,120,847	16,698,897